SCHEMBL7790073

SCHEMBL7790073

Cc1cccc(C(=O)NC(CC(=O)O)c2cccc(N(NC(=N)N)S(=O)(=O)c3ccccc3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 2/20 0.46
CTSA P10619 3/20 0.45
MAPT P10636 3/20 0.42
LMNA P02545 2/20 0.42
ALDH1A1 P00352 3/20 0.41
GAA P10253 1/20 0.41
ITGB3 P05106 2/20 0.41
ITGA2B P08514 2/20 0.41
ALOX12 P18054 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KAT6A Q92794 1/20 0.40
ITGAV P06756 1/20 0.39
GPR139 Q6DWJ6 1/20 0.39
F2 P00734 1/20 0.38
F10 P00742 1/20 0.38
PRSS1 P07477 1/20 0.38
ROCK2 O75116 2/20 0.38
ROCK1 Q13464 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7194899 0.93 ITGB3 (0.44) CYP26A1CTSAMAPTLMNAALDH1A1
SCHEMBL7789969 0.92 CYP26A1 (0.42) CYP26A1CTSAMAPTLMNAALDH1A1
SCHEMBL7785607 0.90 LMNA (0.46) MAPTLMNAALDH1A1GAAITGB3
SCHEMBL7786241 0.90 CTSA (0.46) CTSAALDH1A1GAAITGB3ITGA2B
SCHEMBL7788749 0.88 ITGB3 (0.44) CTSAMAPTLMNAITGB3ITGA2B
SCHEMBL7781206 0.88 ITGB3 (0.42) CTSAMAPTITGB3ITGA2BALOX12
SCHEMBL7786214 0.87 S1PR3 (0.41) CYP26A1CTSAALDH1A1ITGB3ITGA2B
SCHEMBL7790178 0.87 CTSA (0.41) CYP26A1CTSAMAPTITGB3ITGA2B
SCHEMBL7785658 0.86 LMNA (0.44) CTSAMAPTLMNAALDH1A1ITGB3
SCHEMBL7781180 0.85 EEF2K (0.46) CTSAITGB3ITGA2BF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147079-A2 BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS Bayer Aktiengesellschaft (DE) 2001-10-24 EP disclosed
WO-2000041469-A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed